Roivant Sciences Ltd
F:87S

Watchlist Manager
Roivant Sciences Ltd Logo
Roivant Sciences Ltd
F:87S
Watchlist
Price: 10.885 EUR 2.88% Market Closed
Market Cap: 8B EUR
Have any thoughts about
Roivant Sciences Ltd?
Write Note

Wall Street
Price Targets

87S Price Targets Summary
Roivant Sciences Ltd

Wall Street analysts forecast 87S stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 87S is 15.265 EUR with a low forecast of 11.073 EUR and a high forecast of 20.261 EUR.

Lowest
Price Target
11.073 EUR
2% Upside
Average
Price Target
15.265 EUR
40% Upside
Highest
Price Target
20.261 EUR
86% Upside
Roivant Sciences Ltd Competitors:
Price Targets
MRUS
Merus NV
91% Upside
TGTX
TG Therapeutics Inc
15% Upside
SKYE
Skye Bioscience Inc
343% Upside
OPK
OPKO Health Inc
153% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
27% Upside
TCRX
TScan Therapeutics Inc
202% Upside
BPMC
Blueprint Medicines Corp
31% Upside
096530
Seegene Inc
68% Upside

Revenue
Forecast

Revenue Estimate
Roivant Sciences Ltd

For the last 3 years the compound annual growth rate for Roivant Sciences Ltd's revenue is 74%. The projected CAGR for the next 3 years is 52%.

74%
Past Growth
52%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Roivant Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Roivant Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 87S's stock price target?
Price Target
15.265 EUR

According to Wall Street analysts, the average 1-year price target for 87S is 15.265 EUR with a low forecast of 11.073 EUR and a high forecast of 20.261 EUR.

What is Roivant Sciences Ltd's Revenue forecast?
Projected CAGR
52%

For the last 3 years the compound annual growth rate for Roivant Sciences Ltd's revenue is 74%. The projected CAGR for the next 3 years is 52%.

Back to Top